These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 27325254)

  • 1. Prevalence of autosomal dominant polycystic kidney disease in the European Union.
    Willey CJ; Blais JD; Hall AK; Krasa HB; Makin AJ; Czerwiec FS
    Nephrol Dial Transplant; 2017 Aug; 32(8):1356-1363. PubMed ID: 27325254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.
    Spithoven EM; Kramer A; Meijer E; Orskov B; Wanner C; Abad JM; Aresté N; de la Torre RA; Caskey F; Couchoud C; Finne P; Heaf J; Hoitsma A; de Meester J; Pascual J; Postorino M; Ravani P; Zurriaga O; Jager KJ; Gansevoort RT; ; ;
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4(Suppl 4):iv15-25. PubMed ID: 25165182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.
    Reule S; Sexton DJ; Solid CA; Chen SC; Collins AJ; Foley RN
    Am J Kidney Dis; 2014 Oct; 64(4):592-9. PubMed ID: 25134777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.
    Spithoven EM; Kramer A; Meijer E; Orskov B; Wanner C; Caskey F; Collart F; Finne P; Fogarty DG; Groothoff JW; Hoitsma A; Nogier MB; Postorino M; Ravani P; Zurriaga O; Jager KJ; Gansevoort RT; ; ; ; ;
    Kidney Int; 2014 Dec; 86(6):1244-52. PubMed ID: 24827775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of Autosomal Dominant Polycystic Kidney Disease in Olmsted County.
    Suwabe T; Shukoor S; Chamberlain AM; Killian JM; King BF; Edwards M; Senum SR; Madsen CD; Chebib FT; Hogan MC; Cornec-Le Gall E; Harris PC; Torres VE
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):69-79. PubMed ID: 31791998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the United States.
    McGill RL; Saunders MR; Hayward AL; Chapman AB
    Clin J Am Soc Nephrol; 2022 Jul; 17(7):976-985. PubMed ID: 35725555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition.
    Solazzo A; Testa F; Giovanella S; Busutti M; Furci L; Carrera P; Ferrari M; Ligabue G; Mori G; Leonelli M; Cappelli G; Magistroni R
    PLoS One; 2018; 13(1):e0190430. PubMed ID: 29338003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.
    Ryu H; Park HC; Oh YK; Sangadi I; Wong A; Mei C; Ecder T; Wang AY; Kao TW; Huang JW; Rangan GK; Ahn C
    BMJ Open; 2020 Feb; 10(2):e034103. PubMed ID: 32034027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The societal economic burden of autosomal dominant polycystic kidney disease in the United States.
    Cloutier M; Manceur AM; Guerin A; Aigbogun MS; Oberdhan D; Gauthier-Loiselle M
    BMC Health Serv Res; 2020 Feb; 20(1):126. PubMed ID: 32070341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant polycystic kidney disease in Colombia.
    Camargo JT; González CA; Herrera L; Yomayusa-González N; Ibañez M; Valbuena-García AM; Acuña-Merchán L
    BMC Nephrol; 2023 Jul; 24(1):211. PubMed ID: 37460967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of autosomal dominant polycystic kidney disease patients on peritoneal dialysis: a national retrospective study based on two French registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).
    Sigogne M; Kanagaratnam L; Dupont V; Couchoud C; Verger C; Maheut H; Hazzan M; Halimi JM; Barbe C; Canivet E; Petrache A; Dramé M; Rieu P; Touré F
    Nephrol Dial Transplant; 2018 Nov; 33(11):2020-2026. PubMed ID: 29361078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan.
    Higashihara E; Nutahara K; Kojima M; Tamakoshi A; Yoshiyuki O; Sakai H; Kurokawa K
    Nephron; 1998 Dec; 80(4):421-7. PubMed ID: 9832641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure.
    Shaw C; Simms RJ; Pitcher D; Sandford R
    Nephrol Dial Transplant; 2014 Oct; 29(10):1910-8. PubMed ID: 24737444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression.
    Neijenhuis MK; Kievit W; Perrone RD; Sloan JA; Erwin P; Murad MH; Gevers TJG; Hogan MC; Drenth JPH
    BMC Nephrol; 2017 May; 18(1):169. PubMed ID: 28545401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomagnesaemia is absent in children with autosomal dominant polycystic kidney disease.
    Seeman T; Fořtová M; Sopko B; Průša R; Pohl M; John U
    Ann Clin Biochem; 2019 Jan; 56(1):90-94. PubMed ID: 29874928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal dominant polycystic kidney disease: prevalence of renal neoplasias in surgical kidney specimens.
    Jilg CA; Drendel V; Bacher J; Pisarski P; Neeff H; Drognitz O; Schwardt M; Gläsker S; Malinoc A; Erlic Z; Nunez M; Weber A; Azurmendi P; Schultze-Seemann W; Werner M; Neumann HP
    Nephron Clin Pract; 2013; 123(1-2):13-21. PubMed ID: 23752029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry.
    Pippias M; Stel VS; Aresté-Fosalba N; Couchoud C; Fernandez-Fresnedo G; Finne P; Heaf JG; Hoitsma A; De Meester J; Pálsson R; Ravani P; Segelmark M; Traynor JP; Reisæter AV; Caskey FJ; Jager KJ
    Transplantation; 2016 Sep; 100(9):1955-62. PubMed ID: 26588008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany.
    Neumann HP; Jilg C; Bacher J; Nabulsi Z; Malinoc A; Hummel B; Hoffmann MM; Ortiz-Bruechle N; Glasker S; Pisarski P; Neeff H; Krämer-Guth A; Cybulla M; Hornberger M; Wilpert J; Funk L; Baumert J; Paatz D; Baumann D; Lahl M; Felten H; Hausberg M; Zerres K; Eng C;
    Nephrol Dial Transplant; 2013 Jun; 28(6):1472-87. PubMed ID: 23300259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Regular Screening for Intracranial Aneurysm Necessary in Patients with Autosomal Dominant Polycystic Kidney Disease? A Systematic Review and Meta-analysis.
    Zhou Z; Xu Y; Delcourt C; Shan J; Li Q; Xu J; Hackett ML
    Cerebrovasc Dis; 2017; 44(1-2):75-82. PubMed ID: 28502970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and clinical profile of patients with polycystic kidney disease in southern Brazil.
    Nunes AC; Milani V; Porsch DB; Rossato LB; Mattos CB; Roisenberg I; Barros EJ
    Ren Fail; 2008; 30(2):169-73. PubMed ID: 18300116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.